Evidence map›Paper›PMID 34845799›Full record

ArticleJournal of cardiovascular electrophysiology2022

Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy.

Aadhavi Sridharan, Martin S Maron, Richard T Carrick, Christopher A Madias, Dou Huang, Craig Cooper, Jennifer Drummond, Barry J Maron, Ethan J Rowin

Open access · greenAbstract read
In one paragraph

Article in Journal of cardiovascular electrophysiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. The weight of obesity in hypertrophic cardiomyopathy.Clinical medicine (London, England) · 2023
    Review
  7. What Causes Hypertrophic Cardiomyopathy?The American journal of cardiology · 2022
    Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Aadhavi SridharanDivision of Cardiology, HCM Institute, Tufts Medical Center, Boston, Massachusetts, USA.
Martin S MaronDivision of Cardiology, HCM Institute, Tufts Medical Center, Boston, Massachusetts, USA.
Richard T CarrickDivision of Cardiology, HCM Institute, Tufts Medical Center, Boston, Massachusetts, USA.
Christopher A MadiasDivision of Cardiology, HCM Institute, Tufts Medical Center, Boston, Massachusetts, USA.
Dou HuangDivision of Cardiology, HCM Institute, Tufts Medical Center, Boston, Massachusetts, USA.
Craig CooperDivision of Cardiology, HCM Institute, Tufts Medical Center, Boston, Massachusetts, USA.
Jennifer DrummondDivision of Cardiology, HCM Institute, Tufts Medical Center, Boston, Massachusetts, USA.
Barry J MaronDivision of Cardiology, HCM Institute, Tufts Medical Center, Boston, Massachusetts, USA.
Ethan J RowinDivision of Cardiology, HCM Institute, Tufts Medical Center, Boston, Massachusetts, USA.ORCID 0000-0002-3953-0143
Tufts Medical Center · US

Funding

PATHOPHYSIOLOGY OF MYOCARDIAL DISEASEST32HL007227 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Chulan Kwon, WENDY S POST · 1985 to 2026
$21.2M
NHLBI NIH HHS T32 HL007227
6 · The paper itself

Abstract

backgroundThe impact of comorbid disease states on the development of atrial and ventricular arrhythmias in patients with hypertrophic cardiomyopathy (HCM) remains unresolved.

objectiveEvaluate the association of comorbidities linked to arrhythmias in other cardiovascular diseases (e.g., obesity, systemic hypertension, diabetes, obstructive sleep apnea, renal disorders, tobacco, and alcohol use) to atrial fibrillation (AF) and sudden cardiac death (SCD) events in a large cohort of HCM patients.

methodsA total  of 2269 patients, 54 ± 15 years of age, 1392 males, were evaluated at the Tufts HCM Institute between 2004 and 2018 and followed for an average of 4 ± 3 years for new-onset clinical AF and SCD events (appropriate defibrillation for ventricular tachyarrhythmias, resuscitated cardiac arrest, or SCD).

resultsOne or more comorbidity was present in 75% of HCM patients, including 50% with ≥2 comorbidities, most commonly obesity (body mass index [BMI] ≥ 30 kg/m

conclusionsIn adult HCM patients comorbidities do not appear to impact AF or SCD risk. Therefore, for most patients with HCM, adverse disease related events of AF and SCD appear to be primarily driven by underlying left ventricular and atrial myopathy as opposed to comorbidities.

Indexed as

Atrial FibrillationCardiomyopathy, HypertrophicTachycardia, VentricularAdultComorbidityDeath, Sudden, CardiacHumansMaleRisk Factorsatrial fibrillationcomorbiditieshypertrophic cardiomyopathyobesitysudden death

Identifiers

PMID34845799
PMCPMC10092906
OpenAlexW3216813826

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.